Hims & Hers Health (HIMS) Stock
Direct to consumer telehealth and wellness subscription company. Here's the price, business snapshot, and what's worth knowing about Hims & Hers Health in October 2026.
Hims & Hers Health Inc (HIMS) is a direct‑to‑consumer telehealth and consumer health company offering prescription treatments, over‑the‑counter products and personalised care for sexual health, hair loss, skincare and mental wellbeing. The group combines online consultations, subscription services and product fulfilment to build recurring revenue and scale customer relationships. Investors should note the business is growth‑oriented: expansion of product categories and digital customer acquisition have driven top‑line growth, while profitability can fluctuate with marketing spend, retention rates and regulatory developments. Competition in telehealth and consumer health is strong, and outcomes depend on unit economics and customer lifetime value. Market capitalisation is around $11.16bn. This summary is general educational information, not personal financial advice; it is not a recommendation. Values can rise and fall and returns are not guaranteed — consider suitability, review company filings and consult a qualified financial adviser before investing.
Hims & Hers Health (HIMS) Stock Forecast
Analyst price target, next 12 months
$28.19
-2.8% vs today's $29.00
Price range over the last 12 months
In the middle of its 12-month range
Analysts covering Hims & Hers Health have a consensus 12-month target of $28.19, below the current price of $29.00.
Analyst targets are opinions, not guarantees. Capital at risk. Data as of 5 Oct 2026.
Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.
Sixth Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts suggest holding HIMS stock as its current price is close to its target value.
Financial Health
HIMS & HERS is performing well with strong revenue, good profit margins, and healthy cash flow.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Why You’ll Want to Watch This Stock
Recurring Revenue Focus
Subscriptions and repeat product sales can support predictable revenue, though retention and marketing costs have a strong influence on margins.
Digital‑first Healthcare
Online consultations and streamlined fulfilment enable scale, but regulatory shifts and competitive pressure can affect execution and growth.
Market & Competition
Rising telehealth adoption offers opportunity, while intense competition and pricing pressure mean outcomes can vary between companies.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
